recurrent pancreatic cancer
Showing 1 - 25 of >10,000
Pancreatic Carcinoma Trial in Shanghai (carbon ion radiotherapy)
Recruiting
- Pancreatic Carcinoma
- carbon ion radiotherapy
-
Shanghai, Shanghai, ChinaShanghai Proton and Heavy Ion Center
Apr 25, 2023
Pancreatic Cancer Metastatic Trial (C3 (Metformin, Simvastatin, and Digoxin))
Not yet recruiting
- Pancreatic Cancer Metastatic
- C3 (Metformin, Simvastatin, and Digoxin)
- (no location specified)
Sep 1, 2023
Pancreatic Ductal Adenocarcinoma, Pancreas Adenocarcinoma, Pancreas Cancer Trial in Kansas City (Enfortumab vedotin)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +2 more
- Enfortumab vedotin
-
Kansas City, KansasUniversity of Kansas Cancer Center
Jun 23, 2023
Pancreatic Cancer Trial in Shanghai (Cyberknife plus Pembrolizumab and Trametinib, Cyberknife plus Gemcitabine)
Completed
- Pancreatic Cancer
- Cyberknife plus Pembrolizumab and Trametinib
- Cyberknife plus Gemcitabine
-
Shanghai, Shanghai, ChinaChanghai hospital
Feb 28, 2022
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
- sorafenib tosylate
- +4 more
-
Aurora, Colorado
- +1 more
Sep 8, 2022
Metastatic Malignant Tumor in the Brain, Metastatic Solid Tumor, Recurrent Colorectal Carcinoma Trial in Winston-Salem
Completed
- Metastatic Malignant Neoplasm in the Brain
- +11 more
- Laboratory Biomarker Analysis
- siRNA-transfected Peripheral Blood Mononuclear Cells APN401
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Aug 5, 2022
Recurrent Pancreatic Cancer Trial in Shanghai (Tislelizumab, Nab paclitaxel, Gemcitabine)
Recruiting
- Recurrent Pancreatic Cancer
- Tislelizumab
- +2 more
-
Shanghai, ChinaChanghai Hospital
May 25, 2021
PDAC, Pancreatoduodenectomy, Margin, Resection Trial in Duesseldorf (oncological relevance of the mesopancreas)
Not yet recruiting
- PDAC
- +4 more
- oncological relevance of the mesopancreas
-
Duesseldorf, GermanyUniversity Hospital Duesseldorf, Heinrich Heine University
May 30, 2023
Extrahepatic Bile Duct Adenocarcinoma, Biliary Type, Gallbladder Adenocarcinoma, Biliary Type, Metastatic Pancreatic
Active, not recruiting
- Extrahepatic Bile Duct Adenocarcinoma, Biliary Type
- +27 more
- Durvalumab
- Guadecitabine
-
Los Angeles, California
- +2 more
Aug 5, 2022
Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +15 more
- A2B530
- xT-Onco with HLA-LOH Assay
-
Duarte, California
- +6 more
Feb 10, 2023
Colorectal Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Recurrent Colorectal Carcinoma Trial in Atlanta (XL888,
Active, not recruiting
- Colorectal Adenocarcinoma
- +14 more
- XL888
- Pembrolizumab
-
Atlanta, Georgia
- +2 more
Jul 5, 2022
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Active, not recruiting
- Acinar Cell Adenocarcinoma of the Pancreas
- +3 more
- 6,8-bis(benzylthio)octanoic acid
- +5 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Dec 22, 2021
Advanced Malignant Solid Tumor, Bile Duct Carcinoma, Recurrent Malignant Solid Tumor Trial in Indianapolis, Seattle (Afatinib
Completed
- Advanced Malignant Solid Neoplasm
- +6 more
- Afatinib Dimaleate
- +2 more
-
Indianapolis, Indiana
- +1 more
Jun 3, 2022
Pancreatic Cancer Trial in Stockholm (Mistletoe extract (Iscador Qu), Placebo)
Active, not recruiting
- Pancreatic Cancer
- Mistletoe extract (Iscador Qu)
- Placebo
-
Stockholm, SwedenKathrin Wode
Mar 14, 2022
Resectable Pancreatic Ductal Adenocarcinoma, Recurrent Pancreatic Ductal Adenocarcinoma Trial in Netherlands (Standardized
Enrolling by invitation
- Resectable Pancreatic Ductal Adenocarcinoma
- Recurrent Pancreatic Ductal Adenocarcinoma
- Standardized surveillance
-
Nijmegen, Gelderland, Netherlands
- +8 more
May 17, 2022
Recurrent Pancreatic Ductal Adenocarcinoma Trial in Amsterdam, Rotterdam, Utrecht (Additional stereotactic body radiation
Enrolling by invitation
- Recurrent Pancreatic Ductal Adenocarcinoma
- Additional stereotactic body radiation therapy
-
Amsterdam, Noord-Holland, Netherlands
- +2 more
May 17, 2022
Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +19 more
- A2B694
- xT CDx with HLA-LOH Assay
-
Duarte, California
- +9 more
Sep 22, 2023
Pancreatic Cancer, Periampullary Adenocarcinoma Trial in Baltimore (Stereotactic Body Radiation Therapy (SBRT))
Active, not recruiting
- Pancreatic Cancer
- Periampullary Adenocarcinoma
- Stereotactic Body Radiation Therapy (SBRT)
-
Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 9, 2022
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +3 more
- metformin hydrochloride
- +4 more
-
Cleveland, Ohio
- +1 more
Aug 9, 2021
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in Bronx
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
- paclitaxel
- bryostatin 1
-
Bronx, New YorkMontefiore Medical Center
May 18, 2021
Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v6 and v7 Trial in
Active, not recruiting
- Metastatic Pancreatic Adenocarcinoma
- +2 more
- CXCR4 Antagonist BL-8040
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 9, 2022
Benign Pancreatic Tumor, Chronic Pancreatitis, Recurrent Acute Pancreatitis Trial in Portland (Pancreatectomy, Quality-of-Life
Not yet recruiting
- Benign Pancreatic Neoplasm
- +2 more
- Pancreatectomy
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 7, 2022